IBOV 172,060.43 ▲ 0.42% IPC MEX 72,006.05 ▲ 0.16% MERVAL 2,848,945 — — USD/BRL5.58▲ 0.02% USD/MXN18.58▼ 0.11% USD/CLP982.08▼ 0.22% USD/COP3,288▼ 0.57% USD/PEN3.41▼ 0.02% USD/ARS1,544▼ 0.03% USD/UYU40.52▲ 3.32% USD/PYG6,174▲ 1.84% USD/BOB11.63▲ 1.12% USD/DOP60.48▲ 0.05% USD/CRC446.01▲ 1.79% USD/GTQ7.64▲ 3.18% USD/HNL26.90▲ 0.20% USD/NIO36.62▲ 2.73% USD/VES902.19▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.49▲ 2.33% USD/TTD6.72▲ 2.22% EUR/BRL6.19▼ 0.63% BRENT 93.04 ▲ 0.30% WTI 86.77 ▲ 0.28% IRON ORE 161.91 — — COPPER 6.22 ▼ 0.87% GOLD 3,936 ▼ 1.61% SILVER 50.77 ▼ 2.15% SOY 1,224 ▼ 0.39% CORN 446.75 ▼ 0.28% WHEAT 598.00 ▼ 0.25% COFFEE 269.50 ▼ 0.70% SUGAR 18.30 ▼ 0.97% ORANGE JUICE 146.60 ▼ 0.10% COTTON 82.64 ▲ 5.25% COCOA 4,923 ▲ 3.82% BEEF 218.98 ▼ 0.10% CATTLE 332.63 ▲ 0.69% LITHIUM 61.07 ▲ 1.82% PETR4 43.55 ▼ 3.11% VALE3 64.43 ▼ 0.57% ITUB4 41.72 ▲ 1.26% BBDC4 14.33 ▼ 1.44% ABEV3 15.85 ▲ 0.38% BBAS3 16.89 ▼ 1.23% B3SA3 14.80 ▲ 2.21% WEGE3 51.61 ▲ 1.30% PRIO3 61.47 ▲ 2.42% SUZB3 53.80 ▼ 1.21% RENT3 30.24 ▲ 1.51% AZZA3 15.37 ▲ 4.34% CSAN3 3.03 ▲ 13.06% RAIZ4 0.30 ▼ 98.60% PCAR3 2.54 ▼ 0.78% GMAT3 4.08 ▲ 7.09% PSSA3 45.98 ▼ 1.48% CVCB3 0.86 — 0.00% POSI3 3.32 ▲ 5.40% SLCE3 17.05 ▼ 0.23% NATU3 5.62 ▲ 1.26% BRKM5 2.92 — 0.00% RANI3 8.39 ▼ 0.71% CSNA3 4.52 ▲ 3.20% IBOV 172,060.43 ▲ 0.42% IPC MEX 72,006.05 ▲ 0.16% MERVAL 2,848,945 — — USD/BRL 5.58 ▼ 0.01% USD/MXN 18.58 ▼ 0.10% USD/CLP 982.08 ▼ 0.22% USD/COP 3,288 ▼ 0.57% USD/PEN 3.41 ▼ 0.02% USD/ARS 1,544 ▼ 0.03% USD/UYU 40.52 ▲ 3.32% USD/PYG 6,174 ▲ 3.14% USD/BOB 11.63 ▲ 1.12% USD/DOP 60.48 ▲ 0.05% USD/CRC 446.01 ▲ 1.79% USD/GTQ 7.64 ▲ 3.18% USD/HNL 26.90 ▲ 3.29% USD/NIO 36.62 ▲ 2.73% USD/VES 902.19 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.49 ▲ 2.41% USD/TTD 6.72 ▲ 2.22% EUR/BRL 6.19 ▼ 0.63% BRENT 93.04 ▲ 0.30% WTI 86.77 ▲ 0.28% IRON ORE 161.91 — — COPPER 6.22 ▼ 0.87% GOLD 3,936 ▼ 1.61% SILVER 50.77 ▼ 2.15% SOY 1,224 ▼ 0.39% CORN 446.75 ▼ 0.28% WHEAT 598.00 ▼ 0.25% COFFEE 269.50 ▼ 0.70% SUGAR 18.30 ▼ 0.97% ORANGE JUICE 146.60 ▼ 0.10% COTTON 82.64 ▲ 5.25% COCOA 4,923 ▲ 3.82% BEEF 218.98 ▼ 0.10% CATTLE 332.63 ▲ 0.69% LITHIUM 61.07 ▲ 1.82% PETR4 43.55 ▼ 3.11% VALE3 64.43 ▼ 0.57% ITUB4 41.72 ▲ 1.26% BBDC4 14.33 ▼ 1.44% ABEV3 15.85 ▲ 0.38% BBAS3 16.89 ▼ 1.23% B3SA3 14.80 ▲ 2.21% WEGE3 51.61 ▲ 1.30% PRIO3 61.47 ▲ 2.42% SUZB3 53.80 ▼ 1.21% RENT3 30.24 ▲ 1.51% AZZA3 15.37 ▲ 4.34% CSAN3 3.03 ▲ 13.06% RAIZ4 0.30 ▼ 98.60% PCAR3 2.54 ▼ 0.78% GMAT3 4.08 ▲ 7.09% PSSA3 45.98 ▼ 1.48% CVCB3 0.86 — 0.00% POSI3 3.32 ▲ 5.40% SLCE3 17.05 ▼ 0.23% NATU3 5.62 ▲ 1.26% BRKM5 2.92 — 0.00% RANI3 8.39 ▼ 0.71% CSNA3 4.52 ▲ 3.20%
since 2009
Thursday, November 12, 2026

Covid-19 Brazil

Brazil Gets First Active Ingredients for Oxford/AstraZeneca Vaccine From China

By · · 2 min read

RIO DE JANEIRO, BRAZIL – A first shipment of 88 liters of active ingredients to make Oxford/AstraZeneca’s COVID-19 vaccine in Brazil arrived from China on Saturday, February 6th, essential input to speed the country’s troubled vaccination program.

Fiocruz
The Fiocruz biomedical center can begin filling and finishing 2.8 million doses.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

With those supplies flown into Rio de Janeiro on a cargo plane, the Fiocruz biomedical center can begin filling and finishing 2.8 million doses. The federally funded center expects to receive more ingredients this month to make a total of 15 million shots of the vaccine developed with Oxford University.

The Fiocruz production line, originally scheduled to start producing in December, has sat idle due to delays getting the first shipment of supplies from China.

The AstraZeneca Plc vaccine is the central pillar of Brazil’s national inoculation program and the federal government has ordered material for Fiocruz to make up to 100 million shots. To start inoculating its 210 million people, Brazil has relied initially on the Chinese vaccine developed by Sinovac Biotech Ltd and 2 million ready-to-use AstraZeneca shots imported from India last month.

Pfizer Inc applied on Friday for full regulatory approval in Brazil of its COVID-19 vaccine developed with BioNTech Se, the company said.

It is the second vaccine submitted for registration in Brazil. AstraZeneca applied on Jan. 29 for full regulatory approval of its vaccine.

President Jair Bolsonaro, who says he will not take any COVID-19 shot, is under pressure after a slow and patchy vaccine roll-out in Brazil, which now faces a second wave of infections.

Bolsonaro referred to the virus as a “little flu” but his government faces mounting criticism over its handling of the world’s second-deadliest coronavirus outbreak that has killed more than 231,000 Brazilians.

Sao Paulo’s Butantan biomedical institute said on Saturday it has begun to fill-and-finish 8.6 million doses of Sinovac’s vaccine called Coronavac with ingredients that arrived from China on Wednesday.

Butantan said it expects to receive another supply of ingredients on Wednesday to make an additional 8.7 million doses.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.